1-4 of 4
Brandon N Crumpton
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Intervention and Favorable Biologic Effects of Personalized Neoantigen Vaccines on the Tumor Immune Microenvironment in Smoldering Waldenstrom Macroglobulinemia

Szymon Szymura, Soungchul Cha, Lin Wang, Tiantian Zhang, Zhenyuan Dong, Aaron Anderson, Elizabeth Oh, Zhe Wang, Vincent Lee, Sapna Parshottham, Sheetal Rao, Jasper B Olsem, Brandon N Crumpton, Hans C. Lee, Elisabet E. Manasanch, Sattva S. Neelapu, Sheeba K. Thomas, Larry W. Kwak
Journal: Blood
Blood (2023) 142 (Supplement 1): 212.
https://doi.org/10.1182/blood-2023-182448
Published: 2023
Journal Articles

A Novel Therapeutic DNA Vaccine Elicits Reduction of Tumor Clones and Favorable Perturbations in the Immune Microenvironment in Patients (pts) with Untreated Smoldering Waldenström Macroglobulinemia (sWM)

Sheeba K. Thomas, MD, Soung-chul Cha, PhD, Sapna R Parshottam, MSc, Sheetal S. Rao, PhD, Jasper B. Olsem, B.S.N., Brandon N. Crumpton, Szymon Szymura, PhD, Zhe Wang, PhD, Aaron Anderson, Lei Feng, MS, Hans C. Lee, MD, Elisabet E. Manasanch, MD, Krina K. Patel, MD, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD, Sattva S. Neelapu, MD, Larry W Kwak, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-140007
Published: 2020
Journal Articles

Update of a Phase II Study of Lenalidomide-Elotuzumab As Maintenance Therapy Post-Autologous Stem Cell Transplant (AuSCT) in Patients (Pts) with Multiple Myeloma (MM)

Sheeba K. Thomas, MD, Jatin J. Shah, MD, Armando Morin, M.A., Ashley N. Morphey, M.S.N., Hans C. Lee, MD, Elisabet E. Manasanch, MD, Krina K. Patel, MD, Gregory P. Kaufman, MD, Swami P. Iyer, MD, Lei Feng, MS, Behrang Amini, MD PhD, Muzaffar H. Qazilbash, MD, Qaiser Bashir, MD, Neeraj Saini, MD, Samer A. Srour, MD MS, Ralph J. Johnson, PhD, Brandon N. Crumpton, Mildred D. Stafford, Donna M. Weber, MD, Robert Z. Orlowski, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-139934
Published: 2020
Journal Articles

Updated Results of a Phase II Study of Lenalidomide-Elotuzumab As Maintenance Therapy Post-Autologous Stem Cell Transplant (AuSCT) in Patients (Pts) with Multiple Myeloma (MM)

Sheeba K. Thomas, MD, Jatin J. Shah, MD, Ashley N. Morphey, RN, Hans C. Lee, MD, Elisabet E. Manasanch, MD, Krina K. Patel, MDMSc, Carla P Miller, RN, Suzanne Phillips, RN, Brandon N. Crumpton, Ralph J. Johnson, PhD, Lei Feng, MS, Swaminathan P Iyer, MD, Behrang Amini, MD PhD, Donna M. Weber, MD, Robert Z. Orlowski, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1982.
https://doi.org/10.1182/blood-2018-99-116464
Published: 2018